Actor Kunal Kapoor Launches MetaGO, Doctor-Led Platform for Obesity and Metabolic Health

Actor and entrepreneur Kunal Kapoor has launched MetaGO, a doctor-led metabolic health platform focused on obesity and related metabolic conditions, alongside Varun Sheth and Zaheer Adenwala, his fellow co-founders at healthcare crowdfunding platform Ketto.

The platform combines doctor consultations, metabolic assessments, personalized treatment plans, nutrition guidance, fitness coaching, and ongoing clinical monitoring. According to MetaGO, treatment plans may also include GLP-1 therapies under medical supervision where doctors consider them clinically appropriate.

MetaGO says its continuous-care model uses assessments covering more than 35 biomarkers and includes regular follow-up by specialists such as endocrinologists, diabetologists, cardiologists and internal medicine physicians. The company positions the service as a long-term metabolic care programme rather than a short-term weight-loss intervention.

Kapoor said the idea emerged from the founders’ experience building Ketto and observing families raising funds for serious medical treatment.

In an interview with The Economic Times, Kapoor said the team had seen patients and families dealing with conditions and complications involving diabetes, cardiovascular disease, obesity and other metabolic disorders. According to him, this experience pushed the founders to consider how earlier and more continuous care could address metabolic risks before they progressed further.

“We’re not building a weight-loss company,” Kapoor said in comments reported around the launch.

Kapoor has also argued that metabolic health should not be judged by body weight alone. In his Economic Times interview, he discussed metabolic risks in people who may not appear overweight and described obesity as a complex condition influenced by multiple biological and lifestyle factors.

Also see: Chennai-Based HIVE Launches AI Platform That Uses Verified Clinical Data to Support Doctors and Better Patient Care

According to reports on the launch, MetaGO brings several components of metabolic care into one program, including diagnostics, physician consultations, personalized treatment planning, nutrition support, fitness coaching, and continued monitoring.

Kapoor told The Economic Times that the platform does not intend to provide prescriptions solely on the basis of an online form. He described a process involving diagnostic testing, health-history review and physician assessment before an individual treatment pathway is developed.

The platform says technology supports care delivery, monitoring and data tracking, while clinical decisions remain under medical supervision.

MetaGO’s model also includes specialist involvement. The company says patients may receive follow-up from endocrinologists, diabetologists, cardiologists and internal medicine physicians, depending on individual needs.

MetaGO is launching amid growing attention to GLP-1-based medicines used in the management of obesity and certain metabolic conditions. The company says it does not position these medicines as standalone solutions.

“GLP-1 therapies have genuinely changed what’s possible for many people living with obesity, but medication is only one part of the journey,” Kapoor said in comments released during the launch.

He added that sustained outcomes require medical supervision, nutrition, behaviour change and ongoing support.

“Nobody should be left alone with a strong drug and a printout,” Kapoor told The Economic Times.

In the interview, Kapoor also cautioned against treating GLP-1 medicines as quick-fix weight-loss products. He discussed concerns around treatment without adequate medical oversight, nutrition support, and follow-up, including the possibility that rapid weight loss may involve loss of muscle as well as fat.

MetaGO therefore presents GLP-1 therapy as one potential component of a broader care pathway, subject to clinical assessment and medical supervision.

Also see: Mykare.ai Raises $3.2 Million to Expand AI-Powered Healthcare Platform Across Global Markets

Kapoor told The Economic Times that MetaGO treats maintenance as a defined part of care rather than ending support after initial weight loss.

He said treatment may be adjusted as patients stabilize, with greater emphasis on coaching and sustainable habits. Any medication reduction or discontinuation would depend on individual clinical circumstances and medical oversight.

This approach aligns with the company’s broader positioning around continuous care. MetaGO says its treatment plans combine medical supervision with nutrition, fitness and ongoing monitoring rather than relying on a single intervention.

MetaGO has also begun community outreach. ETEntrepreneur reported that the company recently organized a free metabolic health camp for Mumbai Police personnel, offering blood tests and physician consultations.

The initiative adds a screening and outreach component to the startup’s broader focus on metabolic health.

Its long-term impact will depend on factors including clinical outcomes, patient retention, accessibility and the quality of sustained medical oversight. For now, the launch marks Kapoor, Sheth and Adenwala’s move from medical crowdfunding into long-term metabolic health management.

(Rh/ARC)